UNSPSC 51453701: Hycanthone

This classification denotes an antihelminthic agent with the molecular formula C20H24N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2BXX5EVN2A, chemically known as 9h-thioxanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-(hydroxymethyl)- but generally known as hycanthone, which bears US NIH Compound Identifier 3634. European Medicines Agency schedules Hycanthone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08057MIG.

UNSPSC 51453701 Hycanthone is a Commodity code representing pharmaceutical products procured by state and local health agencies. The code shows minimal recent activity directly aligned with its nominal scope; the two most recent state and local opportunities tagged to this code involve unrelated pharmaceutical purchases. The Illinois Department of Public Health awarded a completed piggyback pharmaceutical warehouse contract to Chartwell Rx LLC in August 2026 for antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) totaling $2,999,999.11 over three years through the MMCAP Infuse cooperative purchasing vehicle, while Seminole County, Florida released an IFB in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to a county health facility. Neither opportunity involves hycanthone specifically, indicating that state and local procurement under this Commodity code does not reflect current active demand or that the code is used sporadically for pharmaceutical warehouse and emergency-response medical supplies.

Geographic activity is limited to Illinois and Florida based on recent postings, with no additional jurisdictions supporting procurement in this category. The issuing bodies are a state health department and a county government. The Illinois award proceeded as a competitive invitation for bid through a cooperative purchasing consortium, while the Seminole County opportunity required electronic bid submission with FEMA compliance provisions. No recent open solicitations for hycanthone itself appear in the available record, suggesting that buyers in this space are currently focused on antibiotics, opioid-reversal agents, and medical waste systems rather than anthelmintic pharmaceuticals.